Boundless Bio Inc.
06/17/2026 | Press release | Distributed by Public on 06/17/2026 08:49
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the annual meeting of stockholders of Boundless Bio, Inc. (the Company) held on June 15, 2026 (the Meeting), two proposals were voted upon by the Company's stockholders. The proposals are described in detail in the Company's definitive proxy statement for the Meeting filed with the U.S. Securities and Exchange Commission on April 28, 2026. Below is a brief description of, and the final results of the votes for, each proposal.
Proposal 1: Each of the director nominees was elected as a Class II director to hold office until the Company's 2029 annual meeting of stockholders, and until their respective successor is duly elected and qualified, by the votes set forth below.
|
Nominee |
Votes For |
Votes Withheld |
Broker Non-Votes |
|||||||||
|
James Christensen, Ph.D. |
9,287,096 |
512,585 |
5,757,105 |
|||||||||
|
Jennifer Lew |
9,271,084 |
528,597 |
5,757,105 |
|||||||||
Proposal 2: The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 by the votes set forth below.
|
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
|||||||||||
|
15,376,973 |
127,747 |
52,066 |
- |
|||||||||||
Boundless Bio Inc. published this content on June 17, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 17, 2026 at 14:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]